Mr. Brent Charleton reports

ENWAVE SIGNS TECHNOLOGY EVALUATION AND LICENSE OPTION AGREEMENT WITH SWISS CANNABIS SELECTION AG, ANNOUNCES SIGNIFICANT EVALUATION RESULTS

EnWave Corp. has entered into a technology evaluation and licence option agreement with Swiss Cannabis Selection AG (SCS), a Switzerland-based medical cannabis company focused on the cultivation, development and production of cannabis and cannabis products for medical purposes. SCS is collaborating with Schibano Pharma AG, a Switzerland-based phytopharmaceutical company specializing in cannabinoid derived active pharmaceutical ingredients, medicinal products and wellness solutions, on the evaluation of EnWave's proprietary Radiant Energy Vacuum (REV) dehydration technology.

Under the terms of the agreement, SCS, in collaboration with Schibano, will conduct a comprehensive evaluation of EnWave's proprietary Radiant Energy Vacuum (REV) dehydration technology for potential application across a range of cannabinoid and botanical products. Upon successful completion of the evaluation program, SCS will have the option to enter into a commercial licence agreement granting certain rights to deploy REV technology within agreed-upon markets and applications.

The agreement follows a series of recent commercial-scale evaluations of REV technology that demonstrated the ability to accelerate drying timelines while maintaining key product quality characteristics. Independent testing conducted across multiple cannabis cultivars showed no statistically significant differences in sensory quality compared with conventionally dried control samples, no meaningful impact on cannabinoid potency, no material change in total yeast and mold counts, and generally stable terpene profiles. The evaluations also demonstrated the potential to reduce overall drying time by approximately two to five days, creating opportunities for increased production throughput and reduced dry-room occupancy.

SCS is collaborating with Schibano on the evaluation program. SCS operates an advanced indoor cannabis cultivation facility and focuses on the production of high-quality medical cannabis under ecological standards and GACP-compliant practices. Schibano operates a vertically integrated seed-to-pharma platform encompassing genetics development, cultivation, extraction, active pharmaceutical ingredient manufacturing and finished product production. It maintains pharmaceutical-quality manufacturing standards and serves customers across international markets. Together, the companies bring complementary expertise spanning cannabis cultivation, pharmaceutical development and cannabinoid product manufacturing.

The evaluation will focus on assessing REV technology's ability to process cannabinoid and botanical materials efficiently while preserving critical quality attributes and meeting the operational and regulatory requirements of SCS and Schibano. Evaluation activities are expected to commence in the coming months.

About EnWave Corp.

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, B.C., EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality and cost.

With more than 50 partners spanning 24 countries and five continents, EnWave's licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner, and getting to market faster with the company's patented technology, licensed machinery and expert guidance.

EnWave's strategy is to sign royalty-bearing commercial licences with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, colour and nutritional value.

We seek Safe Harbor.